Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home

Journal of the American Geriatrics Society

Volumn 44, Issue 9, 1996, Pages 1075-1077

  Aronow, Wilbert S ^a,b,c  

^a American Geriatrics Society   (United States)

^b HEBREW HOSPITAL HOME   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DILTIAZEM; METOPROLOL; NIFEDIPINE; TIMOLOL; VERAPAMIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PREVALENCE; TREATMENT OUTCOME;

EID: 0029812047     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb02941.x     Document Type: Article

References (23)

1. Hawkins CM, Richardson DW, Vokonas PS. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience. Circulation 1983;67(suppl I):94-97.
2. Gundersen T, Abrahamsen AM, Kjekshus J et al. Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Circulation 1982;66:1179-1184.
3. Hjalmarson A, Herlitz J, Holmberg S et al. The Goteborg Metoprolol Trial: Effects on mortality and morbidity in acute myocardial infarction. Circulation 1983;67(suppl I):26-31.
4. Aronow WS, Ahn C, Mercando AD et al. Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction ≥40%. Am J Cardiol 1994;74:267-270.
5. Park KC, Forman DE, Wei JY. Utility of beta-blockade treatment for older postinfarction patients. J Am Geriatr Soc 1995;43:751-755.
6. Held PH, Yusuf S. Impact of calcium channel blockers on mortality in survivors of acute myocardial infarction. In: Singh BN, Wellens HJJ, Hiraoka M, eds. Electropharmacological Control of Cardiac Arrhythmias. Mount Kisco, NY: Futura Publishing Co, Inc, 1994, pp 399-411.
7. Furberg CD, Psaty BM, Meyer JV. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
8. Chadda K, Goldstein S, Byington R et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986;73:503-510.
9. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-392.
10. Goldstein RE, Boccuzzi SJ, Cruess D et al. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991;83:52-60.
11. Elkayam U, Amin J, Mehra A et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990;82:1954-1961.
12. Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardiol 1990;66:1257-1259.
13. Kennedy HL, Brooks MM, Barker AH et al. Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. Am J Cardiol 1994;74:674-680.
14. Aronow WS, Ahn C, Mercando AD et al. Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic effect than an antiarrhythmic effect. Am J Cardiol 1994 74:613-615.
15. Aronow WS, Ahn C, Mercando AD et al. Effect of propranolol on circadian variation of ventricular arrhythmias in elderly patients with heart disease and complex ventricular arrhythmias. Am J Cardiol 1995;75:514-516.
16. Aronow WS, Ahn C, Mercando AD et al. Effect of propranolol on circadian variation of myocardial ischemia in elderly patients with heart disease and complex ventricular arrhythmias. Am J Cardiol 1995;75:837-839.
17. Aronow WS, Ahn C, Mercando AD et al. Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias. Am J Cardiol 1994;74:819-821.
18. Forman DE, Wei JY. Beta-blockade in older patients with myocardial infarction (letter). JAMA 1991;266:2222.
19. Gurwitz JH, Goldberg RJ, Chen Z et al. Beta-blocker therapy in acute myocardial infarction: Evidence for underutilization in the elderly. Am J Med 1992;93:605-610.
20. Rich MW, Bosner MS, Chung MK, et al. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction. Am J Med 1992;92:7-13.
21. Montague TJ, Ikuta RM, Wong RY et al. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two year period (1987-1989). Am J Cardiol 1991;68:843-847.
22. Zuanetti G, Latini R, Avanzini F et al. Use of beta-blocking agents after myocardial infarction. The GISSI experience (abstract). Circulation 1995;92(suppl I):196.
23. Danish Study Group on Verapamil in Myocardial Infarction. Trial II-DAVIT II. Effect of verapamil on mortality and major events after acute myocardial infarction. Am J Cardiol 1990;66:779-785.